Atea Pharmaceuticals is Drug Discovery in United States that focus on Atea Pharmaceuticals Inc business. Founded in 2012. They cover business area such as Atea Pharmaceuticals Inc, therapy, patient, severe viral disease, its program, orally-, direct act antiviral, dengue, severe respiratory syncytial virus infection, virology, pharmacology expertise, its collective experience, drug development, new advancement, antiviral science.
2012
( 12 years old in 2024 )
Atea Pharmaceuticals Inc
-
125 Summer Street
16th Floor
Boston, MA 02110
United States
Private
Atea Pharmaceuticals Inctherapypatientsevere viral diseaseits programorally-direct act antiviraldenguesevere respiratory syncytial virus infectionvirologypharmacology expertiseits collective experiencedrug developmentnew advancementantiviral science
* We use standard office opening hours in near Atea Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Atea Pharmaceuticals is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Atea Pharmaceuticals business is focusing on Atea Pharmaceuticals Inc.
Atea Pharmaceuticals headquarter office and corporate office address is located in 125 Summer Street 16th Floor Boston, MA 02110 United States.
Atea Pharmaceuticals was founded in United States.
In 2024, Atea Pharmaceuticals is currently focus on Atea Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Atea Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Atea Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
